Clinical Trials
1
Active:1
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders Study
Phase 2
Active, not recruiting
- Conditions
- Fetal Alcohol Spectrum Disorders
- Interventions
- First Posted Date
- 2021-11-05
- Last Posted Date
- 2025-07-31
- Lead Sponsor
- Jeff Wozniak
- Target Recruit Count
- 62
- Registration Number
- NCT05108974
- Locations
- 🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States
News
No news found